• Non ci sono risultati.

2 3 4 Β

N/A
N/A
Protected

Academic year: 2021

Condividi "2 3 4 Β"

Copied!
155
0
0

Testo completo

(1)
(2)

2

... 12

... 14

... 18

... 19

... 21

... 26

... 28

... 32

... 34

... 37

... 39

... 41

... 42

... 43

... 45

... 49

... 50

... 59

... 59

... 59

(3)

3

... 67

... 68

... 68

... 73

... 75

... 76

... 78

... 79

... 81

... 84

... 87

Β

Β ... 89 Β

91

(4)

4

... 95

... 97

... 98

... 101

... 105

107 ... 109

... 109

... 110

... 110

... 111

... 111

... 113

(5)

5

(6)

6 β

β

β

β

β

(7)

7

(8)

8

(9)

9 β

α β

β

β

(10)

10

(11)

11

(12)

12 β

β

β γ

β

(13)

13 β

β β

ε

ε ε

β ε

β

(14)

14

ε β

β

β

β

β

β β

β β

β

(15)

15 β

β β

β

γ

β

β β

β

(16)

16 β

β

β

α β

α β

β

α γ

β

α

α β

γ

γ β

β

β

β

(17)

17

α β β

β β

γ β

(18)

18

(19)

19

(20)

20

(21)

21

(22)

22

(23)

23

α

(24)

24 β

β

β

(25)

25

(26)

26

α

(27)

27

(28)

28

(29)

29

(30)

30

(31)

31

(32)

32

β

(33)

33 β

β

β

β β

β β

β

(34)

34 ε

β

β

β

ɣ

β

(35)

35 β

β

β β

β β

β

β

β

β β

β

(36)

36

β

(37)

37

(38)

38 α

β

(39)

39 ɣ

ɣ

(40)

40 β

β ɣ

β α

β

α

α

β

(41)

41 β

β

(42)

42 α

α

β

β

(43)

43

α β

(44)

44 α

β

(45)

45

(46)

46 β

β

(47)

47

(48)

48

(49)

49

(50)

50

(51)

51

(52)

52

(53)

53 β

β

β β

γ

α β α

β α

β

(54)

54

(55)

55

(56)

56

β

(57)

57

(58)

58

(59)

59

(60)

60

(61)

61

(62)

62

(63)

63

(64)

64

β

(65)

65

(66)

66

(67)

67

β β

β

β β

β

(68)

68

(69)

69

(70)

70

α β

(71)

71

(72)

72

(73)

73

(74)

74

(75)

75

(76)

76

(77)

77

(78)

78

(79)

79

(80)

80

(81)

81

(82)

82

(83)

83 β

β

β

β β

WT

CAP2 KO 0

10 20 30 40 50

O.D. Amyloid Beta1-42 (pg/ml) / concentration

**

(84)

84

(85)

85

(86)

86

(87)

87

(88)

88

(89)

89

β

β

β β

β β

β

β β

β

β β

β

β

β

β β

β

β

(90)

90 β

β

β

β

β

β

β β

(91)

91

β β

β β

β β β

β β

β β

β β β β β β

β

β

β β

β

β β

β β

β

β

β

β

(92)

92 β

β

β β

β

β β β

β β

β β β

β

β β

(93)

93

β β

β β

β β β

β

β β

β β β

β

β

β

β

β

β

(94)

94

β

β

β

(95)

95

(96)

96

(97)

97

(98)

98

(99)

99

(100)

100

(101)

101

(102)

102

(103)

103

β

(104)

104

(105)

105 β

β

β

(106)

106

(107)

107

(108)

108

(109)

109

β

(110)

110

(111)

111

(112)

112

(113)

113 α

α

β

(114)

114

α α

α

(115)

115

(116)

116 β

β

β α

(117)

117

β

(118)

118 β

β

(119)

119

β β

β

β

β

β

(120)

120 β

β

β

β

β

β

β β

β β

β

(121)

121

(122)

122

(123)

123

α

(124)

124

(125)

125 β

β

(126)

126 β

β

β

(127)

127 β

β

β

(128)

128 β

β

β

β

β

α

(129)

129 β

β

(130)

130

(131)

131

(132)

132 β

α

(133)

133 β

(134)

134

‐ ‐

(135)

135

(136)

136

β

(137)

137 β

β

β

β

β

β α

β

β

(138)

138 β

β β

β

β

β β

β

β

β

β

(139)

139

β γ

α

(140)

140

α

α

β

(141)

141  

γ

α

α

α α

β

(142)

142

α

(143)

143

(144)

144

(145)

145

β

(146)

146

β

(147)

147

β

(148)

148

(149)

149

(150)

150

(151)

151

(152)

152 This project has received funding

from the European Union’s

Horizon 2020 research and

innovation programme under the

Marie Skłodowska-Curie grant

agreement No 676144

(153)

153

β

(154)

154

(155)

155

Riferimenti

Documenti correlati

This project has received funding from the European Union's Horizon 2020 research and innovation programme under Grant Agreement No 864212.. The sole responsibility of

Josep Quer, Carlo Cecchetto, Caterina Donati, Carlo Geraci, Meltem Kelepir, Roland Pfau, Markus Steinbach (Eds.)..

Josep Quer, Carlo Cecchetto, Caterina Donati, Carlo Geraci, Meltem Kelepir, Roland Pfau, Markus Steinbach (Eds.)..

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101016798... This project has received

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 692976.. FEUTURE Online

Office of Nursing Services and Midwifery Director Health Service Executive Ireland Nurse and midwifery clinical nurse specialist registered prescribing survey [Online].

Costs for ERC additional funding (e.g. start-up costs, major equipment, access to large facilities, major experimental and field work costs) are eligible, if and as

The EUCalc project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant ag reement